David Y Zhang

Natura-Alpha Targets Forkhead Box M1 and Inhibits Androgen-Dependent and -Independent Prostate Cancer Growth and Invasion

Simon K. Mencher, Longgui Wang, Jinhua Wang, 2011, Clinical Cancer Research.

Targeted alpha therapy for cancer

Yong Li, J. Kearsley, B. Allen, 2004, Physics in medicine and biology.

Anticancer Activities of Oldenlandia diffusa

Jun Shao, Jizu Yi, J. Shao, 2004, Journal of herbal pharmacotherapy.

Cytotoxicity of human prostate cancer cell lines in vitro and induction of apoptosis using 213Bi-Herceptin alpha-conjugate.

Yong Li, B. Allen, P. Cozzi, 2004, Cancer letters.

Cytotoxicity of breast cancer cells overexpressing HER2/neu by 213Bi-Herceptin radioimmunoconjugate.

Yong Li, J. Kearsley, B. Allen, 2005, Cancer letters.

Abstract 1643: AZD4547, a potent and selective inhibitor of FGF-receptor tyrosine kinases 1, 2 and 3, inhibits the growth of FGF-receptor 2 driven gastric cancer modelsin vitroandin vivo

E. Kilgour, Q. Ji, X. Su, 2011 .

212 Tumor adjacent cytokine factories for eradication of ovarian cancer tumor burden in mice through cytotoxic T-cell activation with safe and predictable dosing in non-human primates

A. Jazaeri, O. Igoshin, O. Veiseh, 2021, Journal for ImmunoTherapy of Cancer.

MUC1 expression in primary and metastatic pancreatic cancer cells for in vitro treatment by 213Bi-C595 radioimmunoconjugate

A. Perkins, Yong Li, J. Samra, 2004, British Journal of Cancer.